126 related articles for article (PubMed ID: 12527417)
1. Mitochondrially mediated synergistic cell killing by bile acids.
Rolo AP; Palmeira CM; Wallace KB
Biochim Biophys Acta; 2003 Jan; 1637(1):127-32. PubMed ID: 12527417
[TBL] [Abstract][Full Text] [Related]
2. Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergism.
Rolo AP; Palmeira CM; Wallace KB
Toxicol Lett; 2002 Feb; 126(3):197-203. PubMed ID: 11814708
[TBL] [Abstract][Full Text] [Related]
3. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
Katona M; Hegyi P; Kui B; Balla Z; Rakonczay Z; Rázga Z; Tiszlavicz L; Maléth J; Venglovecz V
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G193-204. PubMed ID: 26608189
[TBL] [Abstract][Full Text] [Related]
4. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
Rolo AP; Palmeira CM; Holy JM; Wallace KB
Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
[TBL] [Abstract][Full Text] [Related]
5. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
7. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.
Botla R; Spivey JR; Aguilar H; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 1995 Feb; 272(2):930-8. PubMed ID: 7853211
[TBL] [Abstract][Full Text] [Related]
9. Disruption of mitochondrial calcium homeostasis after chronic alpha-naphthylisothiocyanate administration: relevance for cholestasis.
Rolo AP; Oliveira PJ; Seiça R; Santos MS; Moreno AJ; Palmeira CM
J Investig Med; 2002 May; 50(3):193-200. PubMed ID: 12033284
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
Xiao ZL; Biancani P; Carey MC; Behar J
Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
14. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy.
Rolo AP; Oliveira PJ; Moreno AJ; Palmeira CM
Toxicol Sci; 2000 Sep; 57(1):177-85. PubMed ID: 10966524
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.
Kon K; Kim JS; Jaeschke H; Lemasters JJ
Hepatology; 2004 Nov; 40(5):1170-9. PubMed ID: 15486922
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.
Krähenbühl S; Fischer S; Talos C; Reichen J
Hepatology; 1994 Dec; 20(6):1595-601. PubMed ID: 7982660
[TBL] [Abstract][Full Text] [Related]
17. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations.
Fricker G; Fahr A; Beglinger C; Kissel T; Reiter G; Drewe J
Br J Pharmacol; 1996 Jan; 117(1):217-23. PubMed ID: 8825366
[TBL] [Abstract][Full Text] [Related]
18. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition.
Yerushalmi B; Dahl R; Devereaux MW; Gumpricht E; Sokol RJ
Hepatology; 2001 Mar; 33(3):616-26. PubMed ID: 11230742
[TBL] [Abstract][Full Text] [Related]
19. Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases.
Gores GJ; Miyoshi H; Botla R; Aguilar HI; Bronk SF
Biochim Biophys Acta; 1998 Aug; 1366(1-2):167-75. PubMed ID: 9714791
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
